180
Participants
Start Date
April 18, 2023
Primary Completion Date
August 29, 2024
Study Completion Date
August 29, 2024
Fosifloxuridine Nafalbenamide
Intravenous infusion
Leucovorin
Intravenous infusion
Irinotecan
Intravenous infusion
Bevacizumab
Intravenous infusion
5-FU
Intravenous infusion
Hospital Universitari Vall d'Hebrón, Barcelona
Hospital Duran i Reynals, Barcelona
Hôpital Européen Marseille, Marseille
Charité Campus Virchow-Klinikum, Berlin
Complejo Hospitalario Universitario de Santiago (CHUS), Santiago de Compostela
Helen F. Graham Cancer Center, Newark
Georgetown University Medical Center, Washington D.C.
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan
Centre Georges-François Leclerc, Dijon
Hospital de León, León
Centre Hospitalier Régional et Universitaire de Besançon - Hôpital Jean-Minjoz, Besançon
Hospital Universitari Arnau de Vilanova, Lleida
Hospital General Universitario Gregorio Marañón, Madrid
MD Anderson Cancer Center Madrid, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario Puerta de Hierro, Majadahonda
Hospital Universitario Fundación Alcorcón, Alcorcón
Hospital Universitario Virgen de la Victoria, Málaga
University of Florida Health Medical Oncology - Davis Cancer Pavilion, Gainesville
Institut Bergonié, Bordeaux
Istituto Oncologico Veneto - IRCCS, Padua
Norton Cancer Institute, Louisville
Hospital Universitario Virgen del Rocío, Seville
Centre Hospitalier UniversitaireNantes - Hôtel Dieu, Nantes
The Christ Hospital Cancer Center, Cincinnati
Ospedale Santa Maria delle Croci di Ravenna, Faenza
Barbara Ann Karmanos Cancer Institute, Detroit
Azienda Ospedaliero Universitaria Careggi, Florence
University of Iowa Hospitals and Clinics, Iowa City
Azienda Ospedaliero Universitaria Ospedali Riuniti di Ancona, Ancona
Krankenhaus Nordwest, Frankfurt am Main
Strasbourg Oncology Liberale - Clinique Sainte-Anne, Strasbourg
Cancer Center of Kansas, Wichita
Hôpital Européen Georges-Pompidou, Paris
Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
University of Texas Southwestern Medical Center, Dallas
USOR - Texas Oncology Northeast Texas, Tyler
Azienda Ospedaliera Universitaria - Università degli Studi della Campania Luigi Vanvitelli, Napoli
München Klinik Neuperlach, München
Azienda Ospedaliera Regionale San Carlo, Potenza
Centre Hospitalier Universitaire de Poitiers, Poitiers
Universitätsklinik Ulm - Oberen Eselsberg, Ulm
Hôpital Foch, Suresnes
Fred Hutchinson Cancer Center at Evergreen Health, Kirkland
Northwest Cancer Specialists, P.C. dba Compass Oncology - Vancouver Cancer Center, Vancouver
Boston Medical Center, Boston
University of Massachusetts Worcester, Worcester
Morristown Medical Center, Morristown
Institut Català d'Oncologia - ICO Badalona - Hospital Universitari Germans Trias i Pujol, Badalona
Hospital de la Santa Creu i Sant Pau, Barcelona
Queen's Hospital, Romford
University College London Hospitals NHS Foundation Trust, London
Royal Free London NHS Foundation Trust, London
Guy's and Saint Thomas' NHS Foundation Trust, London
The Christie NHS Foundation Trust, Manchester
Mount Vernon Cancer Centre - East and North Hertfordshire NHS Trust, Northwood
Velindre University NHS Trust, Cardiff
NHS Greater Glasgow and Clyde, Glasgow
Lead Sponsor
NuCana plc
OTHER